Fresh2 Group Ltd (FRES) - Forward P/S Multiple

Corporate emblem and logo of Fresh2 Group (FRES)

Fresh2 Group Limited is implementing ESG standards in B2B logistics to minimize its carbon footprint. Stable demand is driven by software for verifying the safety of agricultural products from China. Simultaneously, the company is expanding its staff of IT specialists and laboratory technicians. The forward revenue multiple illustrates the current business valuation, while 1.20 marks a new level, determining the balance between yield and investor risk.

FRES Fresh2 Group: Market Cap to Expected Sales Ratio in the range 02/21/2024 - 09/30/2024

Summary analytical data breakdowns for fresh2.co (FRES)

- market price and analyst price targets:
Price Chart Fresh2 Group|FRES - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Fresh2 Group Limited|FRES - Total Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Fresh2 Group|FRES - Book Valuation of Business|Market Capitalization to Book Value Ratio fresh2.co|FRES - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Fresh2 Group Limited|FRES - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Fresh2 Group|FRES - Company Aggregate Debts|Debt to Net Assets Fresh2 Group Limited|FRES - Company Long-Term Debt|Company Short-Term Loans and Borrowings Fresh2 Group|Immediate Liquidity fresh2.co
- business earnings and investment ratios data:
FRES - Net Income|Projected Future Earnings Fresh2 Group Limited|FRES - Price to Earnings Ratio|Price to Expected Earnings Ratio Fresh2 Group|FRES - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Fresh2 Group Limited|FRES - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Fresh2 Group|FRES - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months fresh2.co|FRES - Earnings per share growth in current year|Expected earnings per share growth for next year Fresh2 Group Limited
- sales volume and revenue indicators:
FRES - Revenue and Sales Volume|Company Future Sales Fresh2 Group|FRES - Market Cap to Revenue|Price to Expected Revenue Ratio Fresh2 Group Limited
Fundamental company analysis:Fresh2, FRES
Original product of Fresh2 Group Ltd

The trade confrontation between the US and China creates risks for Fresh2 Group Limited (FRES) logistics, making the monitoring of the expected P/S multiple critically important. This indicator compares current market capitalization with projected annual revenue, allowing investors to determine if the price is overheated relative to actual business scaling and to assess the company's fundamental margin of safety amid declining profitability.

Who Fresh2 Group Limited competes with

Price-to-Projected Revenue Ratio Agilent A|Forward Price to Sales DGX|Illumina Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Exact Sciences Inc.|Revvity, Inc. (RVTY) - Price-to-Projected Revenue Ratio|BIO - Market Cap to Expected Sales Ratio|NNNN (Anbio) - Forward P/S Multiple|SHC: Forward Price to Sales|Price-to-Projected Revenue Ratio QuidelOrtho Corp (QDEL)|Forward Price-to-Revenue Multiple OPKO Health Corp. OPK|Forward Price to Sales CareDx, Inc|Forward P/S Multiple maravai.com MRVI|Projected Price to Revenue FLGT|LAB: Price-to-Projected Revenue Ratio|Forward Price to Sales Cytek Bio CTKB|OSUR (OraSure Corp) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio XGN (Exagen Inc)|Forward Price-to-Revenue Multiple mdxhealth.com (MDXH)|Forward P/S Multiple LUCD|Price-to-Projected Revenue Ratio PRE (prenetics.com)|Insight Molecular Diagnostics Inc (IMDX) - Future Price to Revenue|TRIB - Forward Price-to-Revenue Multiple|Forward Price to Sales ProPhase Labs, Inc. (PRPH)|AIMD: Price-to-Projected Revenue Ratio|Co-Diagnostics (CODX) - Price-to-Projected Revenue Ratio|Heart Test Laboratories, Inc. (HSCS) - Forward P/S Multiple|BMRA: Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio CDIO|Forward Price-to-Revenue Multiple ONCO (Onconetix, Inc.)|Forward P/S Multiple viraxbiolabs.com (VRAX)|Market Cap to Expected Sales Ratio BJDX|AWH - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio Accelerate Diagnostics, Inc AXDX|CNTG - Forward P/S Multiple|Market Cap to Future Revenue Ratio ENZ|Genetic Technologies Limited (GENE) - Forward P/S Multiple|Market Cap to Projected Revenue 23andMe (ME)|Forward P/S Multiple Psychemedics Corp.